Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis
- PMID: 38533025
- PMCID: PMC10963384
- DOI: 10.1016/j.heliyon.2024.e28127
Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis
Abstract
Rheumatoid arthritis is a chronic systemic autoimmune disease that involves mainly synovitis and joint injury and is one of the main causes of disability. The pathogenesis of rheumatoid arthritis is complicated, and the treatment cycle is long. The traditional methods of inhibiting inflammation and immunosuppression are no longer sufficient for treatment of the disease, so there is an urgent need to seek new treatments. The exocrine microenvironment is a kind of microvesicle with a lipid bilayer membrane structure that can be secreted by most cells in the body. This structure contains cell-specific proteins, lipids and nucleic acids that can transmit this information from one cell to another. To achieve cell-to-cell communication. Exocrine microRNAs can be contained in exocrine cells and can be selectively transferred to target receptor cells via exocrine signaling, thus regulating the physiological function of target cells. This article focuses on the pathological changes that occur during the development of rheumatoid arthritis and the biological regulation of exocrine and exocrine microRNAs in rheumatoid joints. Research on the roles of exocrine and exocrine microRNAs in regulating the inflammatory response, cell proliferation/apoptosis, autophagy, effects on fibroblast-like synoviocytes and immune regulation in rheumatoid arthritis was reviewed. In addition, the challenges faced by this new treatment are discussed.
Keywords: Exosome mRNAs; Exosomes; Immunity; Mechanism of action; Rheumatoid arthritis.
© 2024 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Dysregulation of circRNAs in rheumatoid arthritis, with special emphasis on circRNAs secreted by exosomes and the crosstalk between circRNAs and RNA methylations.Int Immunopharmacol. 2023 Sep;122:110549. doi: 10.1016/j.intimp.2023.110549. Epub 2023 Jul 6. Int Immunopharmacol. 2023. PMID: 37421778 Review.
-
The inhibition by human MSCs-derived miRNA-124a overexpression exosomes in the proliferation and migration of rheumatoid arthritis-related fibroblast-like synoviocyte cell.BMC Musculoskelet Disord. 2020 Mar 6;21(1):150. doi: 10.1186/s12891-020-3159-y. BMC Musculoskelet Disord. 2020. PMID: 32143603 Free PMC article.
-
Exosomal miRNAs involvement in pathogenesis, diagnosis, and treatment of rheumatoid arthritis.Heliyon. 2025 Jan 15;11(2):e41983. doi: 10.1016/j.heliyon.2025.e41983. eCollection 2025 Jan 30. Heliyon. 2025. PMID: 39897907 Free PMC article. Review.
-
Exosomal long non-coding RNA TRAFD1-4:1 derived from fibroblast-like synoviocytes suppresses chondrocyte proliferation and migration by degrading cartilage extracellular matrix in rheumatoid arthritis.Exp Cell Res. 2023 Jan 15;422(2):113441. doi: 10.1016/j.yexcr.2022.113441. Epub 2022 Dec 6. Exp Cell Res. 2023. PMID: 36481205
-
miR-205-5p in exosomes divided from chondrogenic mesenchymal stem cells alleviated rheumatoid arthritis via regulating MDM2 in fibroblast-like synoviocytes.J Musculoskelet Neuronal Interact. 2022 Mar 1;22(1):132-141. J Musculoskelet Neuronal Interact. 2022. PMID: 35234168 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources